Thalidomide given intraperitoneally reduces the number of postoperative adhesions after large bowel resection in rabbits

European Journal of Surgery

Volumn 168, Issue 11, 2002, Pages 641-645

  Mall, Julian W ^a   Schwenk, Wolfgang ^a   Philipp, Andreas W ^a   Müller, Joachim M ^a   Pollmann, Christian ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Adhesion; Large bowel resection; Rabbit model; Thalidomide

Indexed keywords

THALIDOMIDE;

ADHESION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COLON ANASTOMOSIS; COLON RESECTION; CONTROLLED STUDY; DRUG EFFECT; LEUKOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; RABBIT; WEIGHT;

ADHESIONS; ANGIOGENESIS INHIBITORS; ANIMALS; COLON; FEMALE; INJECTIONS, INTRAPERITONEAL; POSTOPERATIVE COMPLICATIONS; RABBITS; THALIDOMIDE;

EID: 0036956507     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/11024150201680013     Document Type: Article

References (23)

1. Ar'Rajab A, Mileski W, Sentementes JT, Sikes P, Harris RB, Dawidson IJ. The role of neutrophils in peritoneal adhesion formation. J Surg Res 1996; 61: 143-146.
2. Barkley ASJ, Bather PC, Allen BR. Retinoids enhance monocyte /endothelium interaction. J Invest Dermatol 1987; 89: 320.
3. Chegini N. The role of growth factors in peritoneal healing: transforming growth factor β (TGF-β). Eur J Surg 1997; 577 (suppl.): 17-23.
4. Ching LM, Xu ZF, Gummer BH, Palmer BD, Joseph WR, Baguley BC. Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5, 6-dimethylxanthenone-4 acetic acid. Br J Cancer 1995; 72: 339-343.
5. Dunzendorfer S, Schratzberger P, Reinisch N, Kähler CM, Wiedermann CJ. Effects of thalidomide on neutrophils respiratory burst, chemotaxis and transmigration of cytokine- and endotoxin-activated endothelium. Naunyn Schmiedebergs Arch Pharmakol 1997; 356: 529-535.
6. Fauré M, Lejeune JP, Gaucherand M, Thivolet J. PMN leucocytes chemotaxis: inhibition by thalidomide. Pathol Biol 1981; 29: 601-604.
7. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985; 82: 8667-8671.
8. Geist C, Wöhrmann J, Schneider K, Zwingenberger K (1995). Effects of thalidomide on the local Shwartzman reaction in mice and rabbits. FEMS Immunol Med Microbiol 1995;12: 165-174.
9. Hofbauer R, Kaye AD, Kapiotis S, Frass M. The immune system and the effects of non-volatile anesthetics on neutrophil transmigration through endothelial cell monolayers. Curr Pharm Des 1999; 5: 1015-1027.
10. Miller JM, Ginsberg M, Mc Elfatrick GC, Shonberg IL. The anti-inflammatory effect and the analgesic property of thalidomide. Antibiot Med Clin Ther 1960; 7: 743-746.
11. Nawroth P, Banks I, Handley D, Cassimeris J, Chess L, Stern D. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 1986; 163: 1363-1375.
12. Netea MG, Blok WL, Kullberg BJ et al. Pharmacologic inhibitors of tumor necrosis α production exert differential effects in lethal endotoxemia and in infection with live organisms in mice. J Infect Dis 1995; 171: 393-399.
13. Nogeira AC, Gräfe M, Neubert R. Effect of Thalidomide and some derivates on the adhesion of lymphocytes to endothelial cells. Naunyn-Schmiedebergs Arch Pharmakol 1995; 351 (Suppl) R130.
14. Saltzman AK, Olson TA, Mohanraj D, Carson LF, Ramakrishnan S. Prevention of postoperative adhesions by an antibody to vascular permeability factor/vascular endothelial growth factor in a murine model. Am J Obstet Gynecol 1996; 174: 1502-1506.
15. Sato N, Goto T, Haranaka K et al. Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition and cytotoxicity. J Natl Cancer Inst 1986; 76: 1113-1121.
16. Schmidt H, Rush B, Simonian G, Murphy T, Hsieh J, Condon M. Thalidomide inhibits TNF response and increases survival following endotoxin injection in rats. J Surg Res 1996; 63: 143-146.
17. Shalaby MR, Waage A, Aarden L, Espevik T. Endotoxin, tumor necrosis factor α and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopath 1989; 53: 488-498.
18. Stephens TD, Bunde CJW, Fillmore BJ. Mechanism of action in thalidomide teratogenesis. Biochem Pharm 2000; 12: 1489-1499.
19. 1), tumor necrosis factor α (TNF-α) and interleukin 1 β (IL 1β). Thromb Haemost 1998; 79: 362-370.
20. Tyrell J, Silberman H, Cbandrasoma P, Niland J, Shull J. Absorbable versus permanent mesh in abdominal operations. Surg Gynecol Obstet 1989; 168: 227-232.
21. Wicyk HP, Grow DR, Adams LA, O'Shea DL, Reece MT. Pelvic adhesions contain sex steroid receptors and produce angiogenic growth factors. Fertil Steril 1998; 69: 511-516.
22. Wnendt S, Finkam M, Winter W, Ossig J, Raabe G, Zwingenberger K. Enantioselective inhibition of TNF release by thalidomide and thalidomide-analogues. Chirality 1996; 8: 390-396.
23. Zwingenberger K, Wnendt S. Immunomodulation by thalidomide: systematic review of the literature and of unpublished observations. J Inflamm 1996; 46: 177-211.